Health Care

Mylan said on Monday it would launch the first generic to its allergy auto-injector EpiPen at a discount of more than 50 percent to the branded product's list price.

Rx Savings Solutions CEO Michael Rea said there’s an alternative to the EpiPen that delivers the same dose and active ingredient as Mylan’s device.

St. Jude Medical Inc. on Friday denied allegations made by a research firm that its pacemakers and other heart devices were vulnerable to hacking and other cybersecurity threats.

Cars that wirelessly talk to each other are finally ready for the road, creating the potential to dramatically reduce traffic deaths, improve the safety of self-driving cars and someday maybe even help solve traffic jams, automakers and government officials say.

Mazda Motor Corp. is recalling more than 190,000 CX-7 sport utility vehicles because of a potentially dangerous steering control defect.

More than 30 million children's wristbands distributed at McDonald's restaurants are being recalled because they can cause skin irritation or burns.

Carl Icahn has recently discussed selling his stake in Herbalife to a group including the company's arch-nemesis William Ackman.

Mylan NV said on Thursday it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen, a day after Democratic Presidential candidate Hillary Clinton joined other lawmakers in criticizing the high price of the drug.

As a pharmaceutical company run by U.S. Sen. Joe Manchin's daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum.

Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland.

Florida Governor Rick Scott said Wednesday it is safe to travel to the state despite Florida health officials reporting 15 new travel-related Zika cases statewide.

The outrage over the surging price of Mylan’s (NASDAQ:MYL) EpiPen continues while the company’s board remains silent.

Ford is recalling more than 88,000 cars and SUVs in North America because the engines can stall without warning due to a fuel pump problem.

Pharmaceutical company AstraZeneca plans to sell its antibiotic pills business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included.